The Institute for Research in Biomedicine was founded in 2000 with the clear and ambitious goal of advancing the study of human immunology, with particular emphasis on the mechanisms of host defense.

The IRB benefits from a wide international network of collaborations.

In addition, the IRB provides teaching and training programs for graduate students from Swiss and foreign Universities.

NewsAll news

	26.07.2017 New paper by the Varani Lab The human immune system is trained to recognize and attack foreign pathogens such as viruses or bacteria but it often fails to recognize cancer cells. In recent years,... Read more
	19.06.2017 Prof. Antonio Lanzavecchia receives the 2017 Robert Koch Award The Robert Koch Foundation is jointly awarding the 2017 Robert Koch Award to Professors Antonio Lanzavecchia and Rafi Ahmed. The award recognizes the two immunologists’... Read more
	11.05.2017 New paper by the Cavalli Lab Cytochromes P450 (CYP450s), in particular, CYP19A1 and CYP17A1, are key clinical targets of breast and prostate anticancer therapies, critical players in drug... Read more / Link
	04.04.2017 Discovery of a new vaccine against RSV virus in the cattle, with possible implications for the development of such a vaccine in humans The Institute for Research in Biomedicine (IRB) and the National Institute of Allergy and Infectious Diseases (NIAID, USA), together with the Pirbright Institute (UK)... Read more
	24.03.2017 New paper by the Cejka Lab The laboratory of Prof. Cejka studies how cells repair damaged or broken DNA. DNA can break as a result of exposure to radiation, chemicals or errors during natural... Read more